Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma.

Maryam B. Lustberg; Tanios Bekaii-Saab; Donn Young; Gregory Otterson; William Burak; Abbas Abbas; Barbara McCracken-Bussa; Mark E. Lustberg; Miguel A. Villalona-Calero

doi:10.1097/JTO.0B013E3181D7776D

Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma.

Maryam B. Lustberg
, Tanios Bekaii-Saab
, Donn Young
, Gregory Otterson
, William Burak
, Abbas Abbas
, Barbara McCracken-Bussa
, Mark E. Lustberg
, Miguel A. Villalona-Calero

Department of Internal Medicine, Columbus, Ohio
Department of Center for Biostatistics, Columbus, Ohio
Departments of Surgery, Columbus, Ohio
Ohio State University

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Thoracic Oncology
Volume	5
Issue number	5
DOIs	https://doi.org/10.1097/JTO.0B013E3181D7776D
State	Published - May 1 2010
Externally published	Yes

Disciplines

Medicine and Health Sciences
Gastroenterology
Surgery
Internal Medicine

Access to Document

10.1097/JTO.0B013E3181D7776DLicense: Unspecified

Cite this

Lustberg, M. B., Bekaii-Saab, T., Young, D., Otterson, G., Burak, W., Abbas, A., McCracken-Bussa, B., Lustberg, M. E., & Villalona-Calero, M. A. (2010). Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma. Journal of Thoracic Oncology, 5(5). https://doi.org/10.1097/JTO.0B013E3181D7776D

Lustberg, MB, Bekaii-Saab, T, Young, D, Otterson, G, Burak, W, Abbas, A, McCracken-Bussa, B, Lustberg, ME & Villalona-Calero, MA 2010, 'Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma.', Journal of Thoracic Oncology, vol. 5, no. 5. https://doi.org/10.1097/JTO.0B013E3181D7776D

@article{f0bb185f4dd04e8a999141f67c9b2681,

title = "Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma.",

author = "Lustberg, \{Maryam B.\} and Tanios Bekaii-Saab and Donn Young and Gregory Otterson and William Burak and Abbas Abbas and Barbara McCracken-Bussa and Lustberg, \{Mark E.\} and Villalona-Calero, \{Miguel A.\}",

note = "Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma.",

year = "2010",

month = may,

day = "1",

doi = "10.1097/JTO.0B013E3181D7776D",

language = "American English",

volume = "5",

journal = "Journal of Thoracic Oncology",

number = "5",

}

TY - JOUR

T1 - Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma.

AU - Lustberg, Maryam B.

AU - Bekaii-Saab, Tanios

AU - Young, Donn

AU - Otterson, Gregory

AU - Burak, William

AU - Abbas, Abbas

AU - McCracken-Bussa, Barbara

AU - Lustberg, Mark E.

AU - Villalona-Calero, Miguel A.

N1 - Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma.

PY - 2010/5/1

Y1 - 2010/5/1

UR - http://europepmc.org/articles/PMC3641556

U2 - 10.1097/JTO.0B013E3181D7776D

DO - 10.1097/JTO.0B013E3181D7776D

M3 - Article

VL - 5

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 5

ER -

Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma.

Disciplines

Access to Document

Other files and links

Cite this